Transcatheter aortic valve implantation (TAVI) for the treatment of patients at intermediate risk [EUnetHTA collaborative assessment OTCA06]
Abraha I, Chiarolla E, Corio M, Gillespie F, Migliore A, Cerbo M, Lauvrak V, Fagerlund BC, Harboe I, Stoinska-Scneider A
Record ID 32017000154
English
Authors' objectives:
The health technology assessed is a bioprothesis in the aortic valve deployed using a catheter. The objective of this assessment was to evaluate the relative effectiveness and safety of this technology in contrast to traditional open-heart surgery.
Details
Project Status:
Completed
URL for protocol:
https://www.eunethta.eu/wp-content/uploads/2017/01/FINAL-Project-Plan-WP4-CA-TAVI.pdf?x16454
Year Published:
2018
URL for published report:
https://www.eunethta.eu/wp-content/uploads/2018/12/OTCA06-TAVI-FOR-THE-TREATMENT-OFPATIENTS-AT-INTERMEDIATE-SURGICAL-RISK-FINAL-1.pdf?x16454
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Italy
MeSH Terms
- Aortic Valve Stenosis
- Heart Valve Prosthesis Implantation
- Aortic Valve Insufficiency
- Transcatheter Aortic Valve Replacement
- Risk Factors
Contact
Organisation Name:
The Italian National Agency for Regional Health Services (Agenas)
Contact Address:
Agenzia nazionale per i servizi sanitari regionali, Via Puglie 23, 00187 Rome, Italy
Contact Name:
hta@agenas.it
Contact Email:
hta@agenas.it
Copyright:
Italian Ministry of Health and Agenas
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.